Biotechnology Stocks I Performance Guide: Amicus Therapeutics, Inc. (FOLD)
FOLD has no dividends.
Table and Chart of FOLD Performance
See what a $1,000 investment in FOLD is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| FOLD Returns | |
|---|---|
| Start Date | Oct-31-2014 |
| Start Price | $5.80 |
| End Date | Oct-09-2024 |
| End Price | $10.16 |
| # Prices | 121 |
| Min Date | Dec-30-2016 |
| Min Price | $4.97 |
| Max Date | Dec-31-2020 |
| Max Price | $23.09 |
| Total Return | 75.17% |
| Annualized Return | 5.72% |
| Current Value of $1,000 Purchase | $1,752 |
| Number Returns | 7,260 |
| Average Return | 19.58% |
| Number Profitable Returns | 4,104 |
| Percent Profitable Returns | 56.53% |
| Number Unprofitable Returns | 3,156 |
| Percent Unprofitable Returns | 43.47% |
| Profitable to Unprofitable Returns Ratio | 1.30 |
| FOLD Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $2,024 |
| Beta | -35.990 | Price to Sales | 44.64 |
| Earnings per Share | $0.0000 |
| PE Ratio | -16683000 |
| PE to Growth Ratio | None |
| Price to Book | 6.61 |
| PRICE DATA | |
| 52 Week High | $0.684 |
| 52 Week Low | $14.57 |
| Analyst Target Price | $0.34 |
| 50-Day Moving Average | $9.02 |
| 200-Day Moving Average | $11.08 |
| FINANCIAL DATA | |
| Revenue per Share | $-0.39 |
| Revenue | $-1 |
| Profit Margin | 151.5% |
| Return on Equity | -2.15% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
FOLD Compare Returns with S&P 500
FOLD Trendline Chart
FOLD Moving Average Chart
FOLD Stock Return Map - See Patterns of Gains and Losses
FOLD Stock Returns/Purchase Dates